Quest Partners LLC Buys 2,517 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Quest Partners LLC boosted its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 384.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,171 shares of the company's stock after buying an additional 2,517 shares during the quarter. Quest Partners LLC's holdings in HCA Healthcare were worth $1,289,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Planning Directions Inc. acquired a new position in HCA Healthcare in the third quarter worth about $236,000. Atlanta Consulting Group Advisors LLC bought a new position in shares of HCA Healthcare during the third quarter worth about $311,000. Natixis Advisors LLC raised its stake in shares of HCA Healthcare by 2.3% in the 3rd quarter. Natixis Advisors LLC now owns 110,105 shares of the company's stock worth $44,750,000 after buying an additional 2,459 shares in the last quarter. Mizuho Securities USA LLC grew its holdings in HCA Healthcare by 205.4% during the third quarter. Mizuho Securities USA LLC now owns 45,637 shares of the company's stock worth $18,548,000 after acquiring an additional 30,693 shares during the period. Finally, Simplify Asset Management Inc. boosted its holdings in HCA Healthcare by 67.1% during the third quarter. Simplify Asset Management Inc. now owns 2,351 shares of the company's stock worth $956,000 after buying an additional 944 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

Insider Transactions at HCA Healthcare

In other news, SVP Phillip G. Billington sold 3,897 shares of the business's stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the company's stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now directly owns 6,843 shares in the company, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 15,155 shares of company stock worth $5,608,990. Company insiders own 1.70% of the company's stock.

HCA Healthcare Stock Down 0.6 %

Shares of HCA traded down $2.11 during trading hours on Wednesday, hitting $333.00. 1,426,476 shares of the company were exchanged, compared to its average volume of 1,189,091. The firm's 50 day moving average is $383.10 and its 200-day moving average is $358.30. HCA Healthcare, Inc. has a 52 week low of $245.84 and a 52 week high of $417.14. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The company has a market cap of $84.35 billion, a PE ratio of 15.05, a PEG ratio of 1.32 and a beta of 1.68.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.79%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare's dividend payout ratio is 11.85%.

Wall Street Analyst Weigh In

HCA has been the topic of a number of recent research reports. Wells Fargo & Company lifted their target price on HCA Healthcare from $395.00 to $400.00 and gave the stock an "equal weight" rating in a report on Wednesday, November 6th. Cantor Fitzgerald restated an "overweight" rating and set a $392.00 price target on shares of HCA Healthcare in a report on Tuesday, October 1st. KeyCorp lowered their price objective on shares of HCA Healthcare from $475.00 to $420.00 and set an "overweight" rating on the stock in a research report on Monday, October 28th. Truist Financial lifted their price target on HCA Healthcare from $390.00 to $430.00 and gave the company a "buy" rating in a report on Monday, August 19th. Finally, Wolfe Research upgraded HCA Healthcare to a "strong-buy" rating in a research report on Thursday, August 29th. Five research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $385.00.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.